You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SoC background therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Arterial Hypertension Trial in Sydney (Dose A KER-012, Dose B KER-012, Dose C KER-012)

Recruiting
  • Pulmonary Arterial Hypertension
  • Dose A KER-012
  • +3 more
  • Sydney, Australia
    Macquarie University
Jul 27, 2023

Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

Recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Inclisiran
  • Geneve 14, Switzerland
    Novartis Investigative Site
Nov 14, 2022

Achilles Tendinopathy Trial in Tacoma (Physical Therapy, Shockwave Therapy, Photobiomodulation Therapy)

Recruiting
  • Achilles Tendinopathy
  • Physical Therapy
  • +2 more
  • Tacoma, Washington
    Madigan Army Medical Center
Feb 27, 2023

NSCLC Trial (SABR, SoC systemic therapy)

Recruiting
  • NSCLC
  • SABR
  • SoC systemic therapy
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 7, 2022

Hyperacusis Trial in Rock Island (device, behavioral, other)

Not yet recruiting
  • Hyperacusis
  • Sound therapy using low-level background sound
  • +2 more
  • Rock Island, Illinois
    Augustana College
Jul 26, 2023

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Mesothelioma; Lung Trial in Toronto (Varying Doses of Background and Boost RT)

Active, not recruiting
  • Mesothelioma; Lung
  • Varying Doses of Background and Boost RT
  • Toronto, Ontario, Canada
    Princess Margaret Hospital, University Health Network
Oct 25, 2022

COVID-19 Trial in Chengdu (VV116+SOC, SOC)

Recruiting
  • COVID-19
  • Chengdu, Sichuan, China
    Chengdu Zenitar Biomedical Technology Co., Ltd
Feb 3, 2023

Opioid-use Disorder Trial in United States (OXD01 digital therapy, Standard of Care)

Recruiting
  • Opioid-use Disorder
  • OXD01 digital therapy
  • Standard of Care
  • Birmingham, Alabama
  • +20 more
Nov 18, 2022

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis Pulmonary Exacerbation
  • Sodium Fusidate
  • Placebo
  • (no location specified)
Dec 14, 2022

Knee Osteoarthritis Trial in Tacoma (other, biological, device)

Recruiting
  • Knee Osteoarthritis
  • Physical Therapy
  • +2 more
  • Tacoma, Washington
    Madigan Army Medical Center
Nov 2, 2023

Stable Angina, Chronic Total Occlusion of Coronary Artery Trial in Basildon, Bournemouth (Percutaneous coronary intervention,

Recruiting
  • Stable Angina
  • Chronic Total Occlusion of Coronary Artery
  • Percutaneous coronary intervention
  • Placebo percutaneous coronary intervention
  • Basildon, Essex, United Kingdom
  • +1 more
Jan 23, 2023

Aphasia Trial in New York (Language therapy, Background Music, Aerobic Exercise)

Active, not recruiting
  • Aphasia
  • Language therapy
  • +2 more
  • New York, New York
    NYU Langone Medical Center
Aug 4, 2022

Eosinophilic Granulomatosis With Polyangiitis Trial in Tulsa, Norfolk (Depemokimab, Mepolizumab, Placebo matching mepolizumab)

Not yet recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Depemokimab
  • +3 more
  • Tulsa, Oklahoma
  • +1 more
Jul 19, 2022

Chronic HIV Infection Trial in Kisumu (POC VL and targeted DRM testing., SOC VL testing)

Completed
Has Results
  • Chronic HIV Infection
  • POC VL and targeted DRM testing.
  • SOC VL testing
  • Kisumu, Kenya
    Rtcp-Faces
Dec 5, 2022

Chronic Rhinosinusitis With Nasal Polyps Trial in China (Dupilumab, Placebo, Budesonide)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Beijing, China
  • +9 more
May 31, 2023

Allergic Fungal Rhinosinusitis Trial in Atlanta, Nashville, Houston (Dupilumab 300 MG/2 ML Subcutaneous Solution, Placebo)

Not yet recruiting
  • Allergic Fungal Rhinosinusitis
  • Dupilumab 300 MG/2 ML Subcutaneous Solution
  • Placebo
  • Atlanta, Georgia
  • +3 more
Nov 16, 2022

Russian Clinical and Research Center of Gerontology of Pirogov

Completed
  • COVID-19
  • Mild to Moderate
  • Baricitinib Oral Tablet
  • +3 more
  • Moscow, Russian Federation
  • +1 more
Mar 31, 2022

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

Recruiting
  • GEP-NET
  • +6 more
  • Duarte, California
  • +3 more
Jul 28, 2022

Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)

Recruiting
  • Septic Shock
  • Vasodilatory Shock
  • Angiotensin II
  • Albuquerque, New Mexico
    University of New Mexico Health Sciences Center
Apr 19, 2023

Amyotrophic Lateral Sclerosis Trial in Camperdown, Concord (CNMAu8)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Camperdown, New South Wales, Australia
  • +1 more
Mar 17, 2022

Lupus Nephritis Trial in Worldwide (ianalumab s.c. q4w, ianalumab s.c. q12w, s.c.)

Recruiting
  • Lupus Nephritis
  • ianalumab s.c. q4w
  • +2 more
  • Fairfax, Virginia
  • +37 more
Oct 14, 2022

Pulmonary Arterial Hypertension Trial (Sotatercept)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Sotatercept
  • (no location specified)
Apr 5, 2023